Work

Ctni-28. Phase 1 Study of Brain-penetrant Braf Inhibitor Hsk42360 in Adult Patients With Braf V600-mutated Advanced Solid Tumors or Recurrent Primary Central Nervous System Tumors

Year: 2025

Type: conference-abstract

Source: Neuro-Oncology

DOI: 10.1093/neuonc/noaf201.0525

Authors: Wenbin Li, Zhuang Kang, Lin Shen, Shenglan Li, Mengqian Huang, Weizhen Zhang, Ligen Mo, Hongbo Guo, Wangming Zhang

Institutions: Capital Medical University, Beijing Tian Tan Hospital, Peking University Cancer Hospital, Zhujiang Hospital, Southern Medical University, Guangxi Medical University, Tumor Hospital of Guangxi Medical University

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416140630

Cites:

Cited by:

Related to: